Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops

J Ocul Pharmacol Ther. 2012 Oct;28(5):473-8. doi: 10.1089/jop.2011.0053. Epub 2012 May 3.

Abstract

Purpose: To evaluate the effectiveness of glycerin 1% formulated with the novel and proprietary ophthalmic excipient poly(l-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) (Eyeon Particle Sciences LLC) in extending tear film break-up time (TFBUT) compared with a market-leading artificial tear formulation of propylene glycol (0.3%) and polyethylene glycol (0.4%) (Systane(®) Lubricant Eye Drops; Alcon, Fort Worth, TX).

Methods: This prospective single-center, single visit, randomized, double-masked exploratory trial compared the new formulation and Systane using TFBUT. Noninvasive break-up time (NIBUT) was measured in subjects with asymptomatic to mild (n=5), mild to moderate (n=5), and moderate to severe (n=6) dry eye disease using the TearscopePlus™ at pre-instillation and again at 15, 30, 60, and 120 min after instillation. Fluorescein break-up time (FBUT) was measured at 120 min after instillation.

Results: At 15 min (N=16), the new formulation extended mean NIBUT by 14.67 s (P=0.05) compared with 7.40 s (P=0.34) by Systane. The new formulation had a mean FBUT of 4.92 s longer than Systane at 120 min (P=0.12). With outliers removed (N=13), the difference between the mean NIBUT change from baseline for the new formulation and Systane at 120 min was statistically significant (P=0.03).

Conclusions: This study demonstrates that PLL-g-PEG as a polymer excipient in artificial tears is effective in improving the performance of demulcents to significantly prolong NIBUT at 15 min, and that protective activity from this artificial tear product for 2 or more hours after eye drop instillation is possible.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Double-Blind Method
  • Dry Eye Syndromes / drug therapy*
  • Dry Eye Syndromes / metabolism
  • Excipients / chemistry
  • Female
  • Glycerol / administration & dosage
  • Glycerol / chemistry
  • Glycerol / therapeutic use*
  • Humans
  • Lubrication
  • Male
  • Ophthalmic Solutions / administration & dosage
  • Ophthalmic Solutions / chemistry
  • Ophthalmic Solutions / therapeutic use*
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / chemistry
  • Polyethylene Glycols / therapeutic use*
  • Polylysine / analogs & derivatives
  • Polylysine / chemistry
  • Prospective Studies
  • Severity of Illness Index
  • Tears / metabolism*
  • Time Factors
  • Treatment Outcome

Substances

  • Excipients
  • Ophthalmic Solutions
  • polylysine-graft-(poly(ethylene glycol))
  • Polylysine
  • Polyethylene Glycols
  • Glycerol